-IBIS-1.7.0-
tx
digestive system
indigestion/heartburn
Nutrition

dietary guidelines

eating principles:

• short alkaline fast 3-5 days (see Fasting in materia medica), followed by slow introduction to mild, bland foods

• important to eat in a relaxed environment, stress-free, and to eat slowly

• eat small meals frequently throughout day

• increase foods rich in Vitamin A

fresh juices:

• carrot (Walker, p. 151)

• carrot, beet, and cucumber (Walker, p. 151)

• carrot and parsley (Walker, p. 151)

• carrot, celery, and parsley (Walker, p 151)

• almond milk (Shefi)

• pineapple (Yin-fang and Cheng-jun, p. 79)

Cabbage (raw juice) is an efficacious treatment for gastric ulcers that can be relevant with chronic dyspepsia: 1 liter per day It appears that glutamine is the specific active ingredient. One study has shown it to be effective alone (may stimulate mucin production). (Zhgun AA, et al. Voen Med Zh. 1971 Apr; 4: 36-38; Dunaevskii GA, et al. Vopr Pitan. 1970 Jul; 29(4): 29-33; Vermel EM, et al. Vrach Delo. 1966 Sep; 9: 133-135; Thaly H. Gaz Med Fr. 1965 May 10; 72(9): 1992-1993; Marz, p. 360, 1997)

specific remedies:

• raw potato juice before breakfast (Chao-liang, Qing-rong, Bao-zhen, p. 13)

• eat 1-2 fresh figs in the morning and evening (Yin-fang and Cheng-jun, p. 20)

• eat mango fruit and skin in the morning and evening (Yin-fang and Cheng-jun, p. 35)

• take fresh, half-ripe fruit, peel and crush. Wrap the pulp in clean gauze and squeeze. Drink 1/2 cup q 4 hours three times daily (Yin-fang and Cheng-jun, p. 45)

• eat 2-3 fresh kumquats including the skin in the morning and evening (Yin-fang and Cheng-jun, p. 51)

• eat 60 g of fresh strawberries three times daily before meals (Yin-fang and Cheng-jun, p. 55)

• for indigestion with diarrhea and vomiting: eat 15 g of fresh raspberries twice daily (Yin-fang and Cheng-jun, p. 62)

• eat 60 g of fresh papaya twice daily (Yin-fang and Cheng-jun, p. 90)

• eat 60 g half-ripe tangerines twice daily (Yin-fang and Cheng-jun, p. 97)

• for indigestion with vomiting clear liquid: add 3-5 g ground peppercorns to wine and serve (Chao-liang, Qing-rong, Bao-zhen, p. 89)

avoid:

• meat, alcohol, hot sauces, spicy foods, fried foods, fatty foods, rich foods, salty foods, coffee, caffeine, sweet foods and sugar

supplements

Artichoke Leaf (high-dose standardized extract): One six-week post-marketing surveillance study in patients with non-specific digestive disorders found the extract to be an efficacious and safe phytopharmaceutical with clinically relevant spasmolytic, antiemetic, carminative and lipid-lowering characteristics. (Fintelmann V. ZFA-Zeitschrift fur Allgemeinmedizen. 1996; 2:3-19.)

Cabbage (raw juice): 1 liter/day. It appears that glutamine is the specific active ingredient. One study has shown it to be effective alone (may stimulate mucin production).

Calcium

Glycyrrhiza glabra (Deglycyrrhinated root) 250 mg three times daily, stimulates mucus formation and secretion (Morgan AG, et al. Gut 23:545, 1982; Acta Gastroent. Bel. 46; 459, 1983; Pizzorno, Murray, VI: Ulcer P-2)

footnotes

Fintelmann V. Antidyspeptic and Lipid-lowering Effects of Artichoke Leaf Extract - Results of Clinical Studies into the Efficacy and Tolerance of Hepar-SL® forte Involving 553 Patients. ZFA-Zeitschrift fur Allgemeinmedizen. 1996; 2:3-19.

Abstract: Artichoke leaf extracts (AK) have choleretic, lipid-lowering and hepatoprotective effects. Within the framework of an indicated ambulatory routine therapy, the efficacy and tolerance of high-dose standardized Hepar-SL® forte as AE was investigated in a six-week post-marketing surveillance study (PMS) in patients with non-specific digestive disorders (n=553), by symptom evaluation both through the physician and the patient. This was a prospective, structured, prescription-epidemiological multicenter study with exploratory character as part of the phase IV research program. It was evaluated by descriptive-statistical means. The PMS study involved 52 ambulatory centers. The average patient age was 54.7 years old. The age group distribution was as follows: < 30 years, 3.8%, 30-39 years, 14.7%, 40-49 years, 20.4%,

50-59 years, 17.6%, 60 years and older, 43.5%. 42% were men and 58% were women. The average duration of application was 43.5 days. The most prominent diagnoses were dyspeptic discomforts, functional bile duct discomforts and obstipation. The major clinical picture was that of chronic disorders; the symptoms had been present on average for 155 weeks prior to inclusion in the study. The average total daily dose was 4.75 capsules Hepar-SL® forte (1 capsule contains 320 mg of high-dose, standardized, aqueous dry extract of artichoke leaves [Extr. Cynarae scol. e fol. aquos. sicc.] (3.8-5.5:1). The preparation was typically administered three times daily (1 to 2 capsules). A distorting influence of concomitant medication and diseases was not found. Relative to their severity on inclusion in the PMS study, the observed symptoms regressed after six weeks of treatment on average by 70.5%; the most pronounced regression was found for vomiting (88.3%), nausea (82.4%), abdominal pain (76.2%), loss of appetite (72.3%), obstipation (71.0%), flatulence (68.2%), meteorism (66.0%) and fat intolerance (58.8%). In 85% of patients the global therapeutic efficacy of Hepar-SL® forte was judged by the physicians as excellent or good, in 12% as moderate and in 3% as insufficient or minimal. In spite of the relatively short duration of therapy, sample averaging showed an 11.5% reduction in serum cholesterol from initially 264.24 mg/dl to 233.91 mg/dl (n=302; p<O.OO1). Serum trigylcerides were similarly reduced from initially 214.97 mg/dl to 188.07 mg/dl, corresponding to a decrease of 12.5%. This lowering of lipid levels is in agreement with the results of other relevant clinical studies and the recently established inhibitory effect of the artichoke leaf extract used in this study on cholesterol biosynthesis. During the surveillance study mild adverse events [flatulence (n=5), weakness (n=1), hunger feelings (n=1)] were noticed in seven cases, corresponding to a total adverse effect rate of 1.3%. The PMS study confirms the well-known excellent tolerance of Hepar-SL® forte and the high therapeutic safety of AE preparations documented in the professional literature. The results of this PMS study show the extract to be an efficacious and safe phytopharmaceutical with clinically relevant spasmolytic, antiemetic, carminative and lipid-lowering characteristics which should have a good chance to be of significance in the prevention of arteriosclerosis.

Morgan AG, McAdam WA, Pacsoo C, Darnborough A. A comparison between cimetidine and CAVED S in the treatment of gastric ulceration and subsequent maintenance therapy. Gut 23:545, 1982.

Abstract: In a comparison with cimetidine it was found that glycyrrhiza was equally effective (88% healing rate in 12 weeks).

Person, Ahlbom & Hellers. Inflammatory bowel disease and tobacco smokea case control study. Gut 31:1377-81, 1990.

Abstract: A case control study was carried out in Stockholm, Sweden between 1984-87 to evaluate the association of childhood cigarette smoking and exposure to environmental tobacco smoke and the subsequent development of irritable bowel disease. Over 500 patients were evaluated and it was found that there was a significant increase risk of developing Crohns disease later in life if the child was exposed to secondary cigarette smoke.

Thaly H. A new therapy of peptic ulcer: "the anti-ulcer factor of cabbage". Gaz Med Fr. 1965 May 10; 72(9): 1992-1993.

Vermel EM, et al. Therapeutic use of white cabbage juice. Vrach Delo. 1966 Sep; 9: 133-135.

Zhgun AA, et al. Effect of dehydrated cabbage juice on the secretory, acid- and pepsin-forming function of the stomach. Voen Med Zh. 1971 Apr; 4: 36-38.